Finance

Lists
MBX:TSE
Microbix Biosystems Inc
CA$0.30
-1.64%
(-0.0050) 1D
Nov 11, 11:14:48 AM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MBX...
Open
CA$0.30
High
CA$0.30
Low
CA$0.30
Mkt. cap
41.63M
Avg. vol.
26.20K
Volume
34.00K
52-wk high
CA$0.32
52-wk low
CA$0.21
EPS
-CA$0.04
Beta
0.54
Shares outstanding
136.97M
No. of employees
70
Open
CA$0.30
High
CA$0.30
Low
CA$0.30
Mkt. cap
41.63M
Avg. vol.
26.20K
Volume
34.00K
52-wk high
CA$0.32
52-wk low
CA$0.21
EPS
-CA$0.04
Beta
0.54
Shares outstanding
136.97M
No. of employees
70
News stories
From web sources and news partners
About Microbix Biosystems Inc
CEO-
Employees70
Founded1988
HeadquartersMississauga, Ontario, Canada
SectorHealth Care
IndustryBiotechnology
Websitemicrobix.com
Last report
Aug 13, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (USD)
2.91M / 3.78M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.74M
4.22M
3.38M
4.06M
Cost of goods sold
2.23M
2.49M
1.75M
1.87M
Cost of revenue
2.23M
2.49M
1.75M
1.87M
Research and development expenses
626.76K
557.07K
601.29K
578.22K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.30M
2.13M
2.29M
2.27M
Operating expense
2.92M
2.68M
2.89M
2.85M
Total operating expenses
5.15M
5.17M
4.64M
4.72M
Operating income
-1.41M
-949.19K
-1.26M
-658.18K
Other non operating income
1.00
1.00
-
-1.00
EBT including unusual items
-1.54M
-1.17M
-1.43M
-806.76K
EBT excluding unusual items
-1.54M
-1.17M
-1.43M
-806.76K
Income tax expense
-55.73K
-
-
-
Effective tax rate
3.63%
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.48M
-1.17M
-1.43M
-806.76K
Net profit margin
-39.54%
-27.67%
-42.35%
-19.87%
Earnings per share
-
-
-
-
Interest and investment income
74.68K
71.52K
62.37K
49.76K
Interest expense
-243.00K
-251.72K
-256.38K
-261.21K
Net interest expenses
-168.32K
-180.20K
-194.01K
-211.45K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.04M
-592.76K
-798.84K
-186.45K
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps